Latest Research Trends in BioScience (09 June 2026)

Human organoids reveal how to reverse “irreversible” nerve damage

Journal: Cell Reports

Author: Gibbons G, Fuchsberger T, Abdelgawad M et al., UK

Researchers developed a human corticospinal organoid-spinal connectoid model that reveals how neuronal maturation restricts axon regeneration and demonstrates that targeting maturation-associated transcriptional programs with repurposable drugs can restore post-injury axon regrowth, opening new avenues for CNS repair and regenerative medicine

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

Journal: New England Journal of Medicine

Author: Eileen M et al., 

A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn’t be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%.

Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding

Journal: Nature

Author: Zeng, J., Cheng, Z., Chen, H. et al., USA

Researchers engineered an RNA-guided CRISPR-Cas12a2 system that selectively recognizes cancer-specific mutations and triggers chromatin shredding, inducing DNA damage and cell death in tumor cells, offering a promising precision-medicine strategy for targeting previously undruggable cancer drivers such as mutant p53

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration

Journal: Cancer 

Author: Zhu L, Zhang S, Li B et al., China

Researchers identified STK40 as a key driver of immune evasion in hepatocellular carcinoma, showing that its inhibition restores tumor sensitivity to immune attack, enhances T cell activation, and significantly improves responses to PD-1 blockade, positioning STK40 as a promising target for overcoming immunotherapy resistance

Subscribe to the latest updates in the newsletter

Share your disease area, therapeutic candidate and research objectives.

Related Solutions

Organoid Service

Research Service

Technical Service

ODISEI CNS - Human brain & retinal organoid
solutions for translational CNS discovery.

Please provide the information below, and our team will contact you shortly with brochure and relevant case studies.

Thank you for your submission.

Our team has received your request and will get back to you shortly.
If you do not receive our confirmation email, kindly check your spam or junk folder.